Background: Anesthetic agents, especially volatile anesthetics and nitrous oxide (N 2 O), are suspected to perturb cerebral homeostasis and vascular reactivity. The authors quantified the effects of sevoflurane and propofol as sole anesthetics and in combination with N 2 O on regional cerebral blood flow (rCBF), metabolic rate of oxygen (rCMRO 2 ), and blood volume (rCBV) in the living human brain using positron emission tomography.
KNOWLEDGE about the effects of different anesthetics and anesthetic regimens on cerebral circulation and brain metabolism is of vital clinical importance. Improper use of anesthetic techniques may have deleterious effects on the compromised brain.
The current understanding of the effects of general anesthetics on cerebral blood flow (CBF) and metabolism is largely based on laboratory data using a variety of different animal species and methods. In spite of partly contradictory results, intravenous anesthetics are commonly considered to reduce metabolism and flow to a comparable extent, whereas volatile anesthetics may perturb vascular reactivity, thereby challenging the classic "neuronal activity Ϸ metabolism Ϸ blood flow" paradigm. 1 Even more variable results, depending on the experimental setting, have been reported for nitrous oxide (N 2 O). High concentrations of N 2 O have generally increased CBF and brain metabolism 2 when given alone or with volatile anesthetic. [3] [4] [5] Similarly, adding 70% N 2 O to deep propofol anesthesia increased cerebral blood flow velocity by 20% in humans. 6 Positron emission tomography (PET) allows accurate in vivo quantification with good regional resolution. Our main aim was to quantitatively assess the effects of a volatile anesthetic (sevoflurane) and an intravenous anesthetic (propofol) as sole agents and in combination with N 2 O on regional CBF (rCBF), regional cerebral metabolic rate of oxygen (rCMRO 2 ), and blood volume (rCBV) in the living human brain using repetitive administration of 15 O tracers and PET. From this data, the oxygen extraction fraction (OEF) was also calculated for each of the studied regions. Based on our previous study, 7 we hypothesized that propofol and also sevoflurane would decrease both metabolism and flow compared to the awake state. Adding N 2 O was assumed to increase both metabolism and blood flow but more during sevoflurane than during propofol anesthesia. We also expected to see some extent of reduction in OEF and Additional material related to this article can be found on the ANESTHESIOLOGY Web site. Go to the following address, click on Enhancements Index, and then scroll down to find the appropriate article and link. http://www.anesthesiology.org. Supplementary material can also be accessed on the Web by clicking on the "ArticlePlus" link either in the Table of Contents or at the top of the Abstract or HTML version of the article. vasodilation (increase in rCBV) during sevoflurane and N 2 O.
Our secondary aim was to locate the peak effects of the drugs in greater detail and to identify the corresponding functional structures using voxel-based statistic parametric mapping (SPM) of the relative changes.
Materials and Methods

Subjects and Study Design
The study protocol was approved by Turku University and the Turku University Hospital Ethics Committee (Turku, Finland). After giving written informed consent, eight healthy (American Society of Anesthesiologists physical status class I), right-handed, nonsmoking male volunteers aged 23 (range, 20 -26) years and with body mass index of 24.6 (range, 19.8 -28.7) were enrolled in this open, nonrandomized, five-period study. All subjects underwent a detailed prestudy examination, including laboratory data collection and 12-lead electrocardiography. All subjects confirmed having no history of drug allergies or ongoing medications. Subjects restrained from using alcohol or any medication for 48 h and fasted at least 8 h before induction of anesthesia. 15 O-labeled water, oxygen, and carbon monoxide were used as PET tracers to determine rCBF, rCMRO 2 , and rCBV, respectively, during the awake state (baseline) and four different anesthetic regimens: (1) sevoflurane alone, (2) sevoflurane plus 70% N 2 O (SϩN), (3) propofol alone, and (4) propofol plus 70% N 2 O (PϩN). Sevoflurane and propofol were administered individually to keep a constant depth of anesthesia (titrated to Bispectral Index [BIS] value of 40) throughout the anesthesia. This value was based on our previous PET study characterizing rCBF changes during surgical levels of anesthesia. 7
Anesthesia and Monitoring
No premedication was given. The left radial artery and two large veins in the right forearm were cannulated for arterial sampling and for administration of anesthetic drugs, H 2 15 O-tracer boluses and 2.5% glucose plus 0.45% NaCl infusion (100 ml/h).
Throughout the study session, the electrocardiogram, noninvasive blood pressure, peripheral oxygen saturation, breathing gases (oxygen, carbon dioxide, sevoflurane, nitrous oxide), and nasopharyngeal temperature (during anesthesia only) were monitored using Datex AS3 equipment (Datex-Ohmeda Division, Instrumentarium Corp, Helsinki, Finland). Arterial blood gas analysis and acid-base balance was determined at baseline and at the end of each of the four anesthetic regimens. BIS ® monitor A-1050 with software version 1.22 containing BI revision 3.3 (Aspect Medical Systems, Natick, MA) was used to measure the depth of anesthesia with two active electrodes placed on the temples and one reference electrode in the midline of the forehead. 8 Anesthesia was induced after the awake PET scans via mask with 8% sevoflurane (Sevorane; Abbot Oy, Espoo, Finland) in 100% oxygen. After disappearance of the eyelid reflex, 0.6 mg/kg rocuronium (10 mg/ml Esmeron; Organon, Helsinki, Finland) was administered intravenously to produce muscle relaxation. Subjects were intubated and connected to the Servo 900C ventilator (Siemens-Elema Ab, Solna, Sweden). First, an oxygen-air (30/70) mixture was used with the respiration frequency set to 15/min and ventilation set to 100 ml · kg Ϫ1 · min Ϫ1 . The ventilation was adjusted so that the individual end-tidal carbon dioxide measured before the induction was maintained throughout the anesthesia. Muscle relaxation was monitored using trainof-four and maintained at one or two twitches with bolus doses of rocuronium (5-10 mg). Arterial blood gas analysis and acid-base balance was determined at the end of each of the four anesthetic regimens.
After the induction of anesthesia, the end-tidal concentration of sevoflurane was adjusted so that the depth of anesthesia measured with the BIS ® monitor was as close as possible to 40. After approximately 50 min, 70% N 2 O was added to the anesthetic regimen, and the depth of anesthesia was maintained by adjusting the sevoflurane vaporizer. After approximately 50 min, administration of sevoflurane and N 2 O was terminated, oxygen-air was restarted, and target-controlled infusion of propofol (20 mg/ml Diprivan; AstraZeneca Oy, Masala, Finland) was initiated with a target plasma concentration of 4 g/ml. Infusion was accomplished with a Harvard 22 syringe pump (Harvard Apparatus, South Natick, MA) connected to a portable computer running Stanpump software with pharmacokinetic parameters by Marsh et al. 9 Finally, again after approximately 50 min, N 2 O was added to propofol. During both propofol regimens, the target concentration was adjusted at 0.1-0.2 g/ml steps to maintain BIS at 40. At the end of both propofol regimens, 5-ml arterial blood samples were collected for the determination of plasma propofol concentrations. Plasma was immediately separated and kept frozen at Ϫ70°C until analyzed with high-performance liquid chromatography at Yhtyneet laboratoriot (Helsinki, Finland). 10 The intraassay coefficient of variation of the assay was 7%.
After the PET scans, residual neuromuscular block was reversed with a neostigmine-glycopyrrolate combination, after which the subjects were extubated. They were then monitored until the vital functions had been stable at least for an hour.
PET Assessments
We used 15 O-labeled water to assess rCBF, 15 O-labeled oxygen gas to assess rCMRO 2 , and 15 O-labeled carbon monoxide gas to assess rCBV. All PET studies were performed in a dimly lit room with no sudden loud noises. A plastic head holder was used to minimize head move-ment. PET assessments were performed with the patients awake and during each anesthetic regimen after approximately 15 min stabilization. Each series of scans (H 2 15 O, 15 O 2 , C 15 O) lasted for approximately 35 min. Thus, altogether, 15 (5 ϫ 3) scans were performed in each subject. For anatomic reference, individual magnetic resonance images were acquired with 1.5-T scanner (Siemens Magnetom SP63, Erlangen, Germany) on a separate occasion.
Radiochemistry. 15 O was produced with a low-energy deuteron accelerator, Cyclone 3 (Ion Beam Applications Inc., Louvain-la-Neuve, Belgium) in Turku University Hospital. 11 The 15 O 2 gas (with radiochemical purity of 97%) was used as such or processed either into C 15 O in a charcoal oven 12 or into H 2 15 O by diffusion membrane technique in a continuously working water module. 13 The purity of the 15 O 2 and C 15 O was defined with gas chromatography before each inhalation.
Scanner and Image Reconstruction. A GE Advance PET scanner (General Electric Medical Systems, Milwaukee, WI) was used to assess tracer tissue concentration in 35 slices parallel to the canthomeatal line, spanning over a distance of 150 mm below cranial vertex. The three-dimensional (septa retracted) transaxial spatial resolution, full width at half maximum, at a radius of 10 cm in midplanes (used in the analysis) was 6 mm in the radial and 5 mm in the tangential direction. Axial resolution was 6.5 mm, full width at half maximum. 14 All scan data were corrected for detector dead time, tracer decay, and measured tissue photon attenuation (assessed with the patient awake and after induction of anesthesia with transmission scans using two extracorporeal 68 Ge rod sources to obtain 10 ϫ 10 6 counts/slice). Data were reconstructed into a 128 ϫ 128 matrix using a threedimensional transaxial Hann filter with a 4.6-mm cutoff and an axial Ramp filter with an 8.5-mm cutoff. The field of view was set to 30 cm, resulting in a pixel size of 300 mm/128 ϭ 2.34 mm.
Tracer Delivery and Arterial Samples. For rCBF assessments, a 300-MBq dose of H 2 15 O was administered as a 15-s bolus using an automated infusion system. The 90-s static tissue activity scan was performed in threedimensional mode. The arterial activity was measured using a peristaltic roller pump and a two-channel coincidence detection system (GEMS, Uppsala, Sweden) cross-calibrated with the scanner.
During rCMRO 2 and rCBV assessments, a modified Servo 900C ventilator was used to enable bolus inhalation of 15 O 2 and continuous inhalation of C 15 O in conscious as well as in anesthetized subjects. For rCMRO 2 assessment, a 350-MBq bolus dose of 15 O 2 gas was collected and administered as a single deep inhalation, followed by a 20-s inspiratory pause. Simultaneously, a 5-min dynamic (16 frames) tissue activity scan was performed in three-dimensional mode. Arterial activity was measured as described above. For measuring arterial oxygen content (milliliters of oxygen per liter of arterial blood), manual samples were drawn before administering 15 
For rCBV assessments, the subjects inhaled in 2 min a 700-MBq dose of 7% C 15 O. Two minutes after completing the inhalation, a 4-min static tissue activity scan was performed in three-dimensional mode. Three manual samples were obtained at 2-min intervals during the scan and were measured for arterial (whole blood) activity using an automatic ␥ counter (Wizard 1480; Wallac, Turku, Finland) To ensure that the activity resided in the red blood cells, a 2-ml manual sample was taken after completing each CBV scan. After centrifugation, the activity of plasma and cells were measured with well type ␥ counter (Bicron MW 3Љ ϫ 3Љ; Bicron Corp., Oakridge, TN).
Data Analysis
The tissue tracer activity images were first computed into quantitative images of rCBF, rCMRO 2 , and rCBV by using arterial tracer activity data and the appropriate tracer kinetic models (see Appendix).
Quantitative ROI Analysis. Each subject's anatomic magnetic resonance images and functional PET images were aligned and resliced using either the surface-fit 15 or the amir-fit method 16 to achieve matching image planes. The effects of subject movement were minimized by realigning other parametric images with the awake images for each individual using SPM99 software (see Voxel-based SPM Analyses).
Individual bilateral ROIs were drawn to outline frontal (on nine image planes), parietal (six planes), temporal (seven planes), and occipital gray matter (four planes), as well as the thalamus (three planes), caudate (three planes), putamen (three planes), and cerebellum (three planes). ROIs were transferred to the parametric PET images to obtain values for each structure.
The regional oxygen extraction fraction (rOEF) was calculated for each ROI as the ratio of consumption (rCMRO 2 ) and delivery (rCBF ϫ arterial oxygen content).
Statistical Analysis of ROI and Monitoring Data. Quantitative ROI and monitoring data were analyzed with repeated-measures analysis of variance with the five different stages (baseline, sevoflurane alone, SϩN, propofol alone, and PϩN) as the within factor. A twosided P value of less than 0.05 was considered statistically significant. The effect of increasing N 2 O was studied by forming linear contrasts and analyzing with paired t tests. Tukey-Kramer correction to P values in pairwise comparisons between the stages was applied to maintain the type I error rate at 0.05. Statistical analyses were conducted with SAS (version 8.02; SAS Institute Inc., Cary, NC). Data are presented as mean Ϯ SD if not otherwise stated. Results of the ROI analysis are given as the mean of the left and right hemispheres.
Voxel-based SPM Analyses. Statistical Parametric Mapping software version 99 (SPM99, the Wellcome Department of Cognitive Neurology, University College London, United Kingdom) 17 running on Matlab 5.3 (The MathWorks Inc., Natick, MA) was used to offer visualization of areas of greatest changes in relative 7 rCBF and rCMRO 2 and absolute rCBV.
Parametric (i.e., quantified) rCBF, rCMRO 2 , and rCBV images were used as the source data. SPM99 preprocessing was performed as previously described, 7 including the realignment of PET scans, conversion to common stereotactic space, and smoothing (14-mm kernel). For flow and metabolism data, proportional scaling was necessary to eliminate the effect of large global changes, whereas blood volume data were analyzed in absolute values without global normalization.
Regional drug-induced changes were explored using subtraction analysis with multisubject, multiple-condition models (with eight subjects and five scans per subject) for rCBF, rCMRO 2 , and rCBV data separately. The changes between drug conditions were tested for statistical significance in each voxel using t statistics. From these t statistic maps, areas of greatest changes were located without an a priori hypothesis regarding the spatial distribution of the effect, as anesthetics at the studied concentrations may induce both subtle widespread effects, but also greater localized effects. To visualize both, two levels of inference were defined as follows. 18 Peak effects were revealed by areas where the parallel significant change occurred in every voxel, each with P Ͻ 0.05 (corrected for multiple comparisons). Conversely, the more subtle changes (having lower height threshold) are significant only if they occur in a sufficiently large clusters (defined by the minimum cluster size). Using height threshold T ϭ 3.41 for rCBF data, the cluster level significance P Ͻ 0.05 (corrected) was achieved by adjusting the minimum cluster size to 100 (sevoflurane vs. awake), 50 (propofol vs. awake), 105 (SϩN vs. sevoflurane), or 30 (PϩN vs. propofol). Using height threshold T ϭ 3.47 for rCMRO 2 data, the required minimum cluster sizes were 150 (sevoflurane vs. awake), 100 (propofol vs. awake), or 200 (PϩN vs. propofol).
The original MNI (Montreal Neurologic Institute) coordinates of the peak voxels resulting from statistical analysis were converted to Talairach space 19 using "mni2tal" conversion software, † † and the corresponding brain structures were identified using Talairach Daemon Software. 20
Results
All PET assessments were performed successfully, except the awake rCMRO 2 measurement in the first subject (oxygen content was not analyzed from the arterial samples). BIS was kept near 40 during anesthesia as planned ( fig. 1 ). With sevoflurane alone, the end-tidal concentration range for maintaining BIS at 40 was 1.1-1.9%. After adding N 2 O, the sevoflurane concentration could be reduced on average by 22% (P Ͻ 0.001) while maintaining a steady BIS level. The range of measured plasma concentrations for propofol alone was 2.6 -4.6 g/ml. The introduction of N 2 O did not allow reducing the plasma propofol concentrations (table 1) .
All anesthetic regimens reduced mean arterial pressure on average by 18% compared to awake values (P Ͻ 0.05 for all). Heart rate remained close to awake values, although differences between the anesthetic regimens caused a significant overall effect in the statistical analysis (P ϭ 0.0034). Nasopharyngeal temperatures showed a slight decrease during anesthesia, with 0.24°C average reduction from awake values during the last drug combination (P Ͻ 0.001 overall). The end-tidal carbon dioxide concentrations were well maintained near the awake values (range, 4.6 -5.7%) throughout anesthesia and matched concomitant arterial values ( fig. 1 ) very well. Numeric values for hemodynamic and ventilation monitoring parameters and drug concentrations during the PET assessments are presented in table 1.
rCBF, rCMRO 2 , rOEF, and rCBV
During the awake state, rCBF was 37-55 ml · 100 g Ϫ1 · min Ϫ1 in the studied regions. Propofol reduced absolute rCBF in all studied areas to 53-70% of baseline (P Ͻ 0.001), whereas the reduction by sevoflurane was significant only in the occipital cortex, cerebellum, caudate, and thalamus (73-80% of baseline, P Ͻ 0.01) ( fig.  2 and table 2 ). More detailed regional visualization of areas with largest flow reduction can be seen in figure icantly compared to drug alone in most regions ( fig. 2 ), during PϩN, rCBF was maintained below the awake levels in almost all regions (62-78% of baseline, P Ͻ 0.05 for all except the occipital cortex), whereas SϩN caused a global return to awake rCBF values (83-112% of baseline, not significant). In addition, the absolute flow increases were significantly greater (vs. drugs alone) in the caudate, putamen, and cerebellum (P Ͻ 0.05) during SϩN (range, 4.9 -12.9 ml ⅐ 100 g Ϫ1 ⅐ min Ϫ1 ) than during PϩN (range 4.4 -8.5 ml · 100 g Ϫ1 · min Ϫ1 ). The areas of greatest relative flow increase caused by adding N 2 O to either drug are shown in figure 4 .
During the awake state, rCMRO 2 was 4.2-5.6 ml · 100 g Ϫ1 · min Ϫ1 in the studied regions. Both sevoflurane and propofol markedly reduced rCMRO 2 in all brain areas to 56 -74% and 50 -68% of baseline, respectively (P Ͻ 0.05; fig. 5 and table 2). Areas of greatest relative metabolic reduction are shown in figure 3. Although N 2 O increased rCMRO 2 in parietooccipital regions and the cerebellum during SϩN and in all cortical areas during PϩN, metabolism was maintained at lower than in the awake state (62-82% and 59 -76% of baseline, respectively, P Ͻ 0.01) during all regimens.
During the awake state, rOEF was 0.46 -0.55 in the studied regions. Sevoflurane alone caused a tendency of reduced rOEF (P Ͻ 0.05 in the frontal and occipital cortices and in the cerebellum; fig. 5 and table 3 ). The sevoflurane-N 2 O combination, on the other hand, uniformly reduced OEF on average by 0.12 units in all cortical areas and the cerebellum (P Ͻ 0.05) compared to awake values. Propofol alone or with N 2 O did not affect rOEF compared to baseline in any of the studied regions.
During the awake state rCBV was 2.9 -4.4% in the studied regions. Sevoflurane alone or with N 2 O did not affect rCBV in any of the studied areas ( fig. 2 and table 3) . Propofol with or without N 2 O reduced quantitative
Fig. 2. Absolute values of regional cerebral blood flow (rCBF; ml · 100 g ؊1 · min ؊1 ) and blood volume (rCBV; percent) of region-of-interest (ROI)-defined regions shown as group mean ؎ SD. Significance (corrected for multiple comparisons) of change is indicated with asterisk (vs. awake) or number sign (vs. drug alone):
one symbol for P < 0.05; two symbols for P < 0.01; three symbols for P < 0.001. P ‫؍‬ propofol; P؉N ‫؍‬ propofol plus nitrous oxide; S ‫؍‬ sevoflurane; S؉N ‫؍‬ sevoflurane plus nitrous oxide. 6 ) to reveal changes also outside our ROIs.
Discussion
At concentrations producing a BIS value of 40, propofol reduced rCBF and rCMRO 2 comparably, to approximately 60% of baseline. The intense reduction in cere-bral perfusion was seen also as a reduction in tissue blood volume in the cortex and cerebellum. At the same BIS level, sevoflurane reduced rCBF less than propofol but rCMRO 2 to an extent similar to propofol, thereby causing a tendency of reduced oxygen extraction. Adjunct N 2 O increased both flow and metabolism with either drug. Metabolism was still maintained below the awake values during all regimens, whereas the flowreducing effect of sevoflurane, but not of propofol, was abolished. The combination of sevoflurane and N 2 O especially decreased rOEF. Values are given as group mean Ϯ SD. P ϭ propofol; PϩN ϭ propofol plus nitrous oxide; rCBF ϭ regional cerebral blood flow; rCMRO 2 ϭ regional cerebral metabolic rate of oxygen; S ϭ sevoflurane; SϩN ϭ sevoflurane plus nitrous oxide. 
Table 2. Absolute Regional Cerebral Blood Flow and Metabolic Rate of Oxygen Values of Region-of-interest-defined Structures
Quantitative Effects of Sevoflurane and Propofol on rCMRO 2 and rCBF
Previous information on propofol is quite coherent, and anticipated reductions were seen in both rCMRO 2 21,22 and rCBF. 23, 24 The similar extent of these changes ensured that rOEF was maintained at normal i.e., awake level, suggesting that this drug leaves the coupling of neuronal activity and blood flow intact despite surgical levels of anesthesia.
Also for sevoflurane, the reduction in rCMRO 2 was as anticipated, 25,26 but the reduction was surprisingly sim-ilar to that of propofol, which could suggest that these drugs are actually equally potent suppressors of neuronal metabolism. Regarding the flow effects of sevoflurane, we have previously shown that 1 minimal alveolar concentration (MAC) sevoflurane reduces rCBF by 36 -53% from awake values in similar ROI regions, but the effect was partly due to concomitant reduction in arterial carbon dioxide tension. In the current study, end-tidal carbon dioxide was maintained at baseline level, and we were able to confirm that 1.5% sevoflurane as a sole anesthetic does not increase perfusion in any region in intact human brain Fig. 5 . Absolute values of regional cerebral metabolic rate of oxygen (rCMRO 2 ; ml · 100 g ؊1 · min ؊1 ) and oxygen extraction fraction (rOEF) of region-of-interestdefined regions, shown as group mean ؎ SD. Significance (corrected for multiple comparisons) of change is indicated with asterisk (vs. awake) or number sign (vs. drug alone): one symbol for P < 0.05; two symbols for P < 0.01; three symbols for P < 0.001. P ‫؍‬ propofol; P؉N ‫؍‬ propofol plus nitrous oxide; S ‫؍‬ sevoflurane; S؉N ‫؍‬ sevoflurane plus nitrous oxide. Values are given as group mean Ϯ SD. P ϭ propofol; PϩN ϭ propofol plus nitrous oxide; rCBV ϭ regional cerebral blood volume; rOEF ϭ regional oxygen extraction fraction; S ϭ sevoflurane; SϩN ϭ sevoflurane plus nitrous oxide.
Table 3. Absolute Regional Oxygen Extraction Fraction and Cerebral Blood Volume Values of Region-of-interest-defined Structures
when compared to a proper awake baseline, but rather causes a global declining tendency in rCBF.
Quantitative Effects of Adjunct Nitrous Oxide on rCMRO 2 , rCBF, and rOEF
At sedative doses (20 -50%), N 2 O alone has been shown to increase cerebral blood flow in humans [27] [28] [29] while maintaining coupling, 30 and at high doses (70%), it has been shown to increase flow and metabolism in goats. 2 Adjunct N 2 O has been shown to alleviate or abolish the rCBF (or mean middle cerebral artery flow velocity)-reducing effect of sevoflurane in pigs 31 and humans 32 and that of isoflurane 33 in humans. Similarly, adding N 2 O to propofol has been shown to increase middle cerebral artery flow velocity (vs. propofol alone) in humans. 6 Our rCBF findings agree well with these studies: N 2 O increased metabolism and flow with both anesthetics. The increases in rCMRO 2 and rCBF (vs. drug alone) were more pronounced during SϩN than during PϩN. This may be partly explained by the fact that the sevoflurane concentration, but not that of propofol, was reduced during adjunct N 2 O, because the BIS ® monitor did not detect N 2 O-related deepening of anesthesia during PϩN the same way as previously reported for remifentanilpropofol, 34 fentanyl-midazolam, 35 and isoflurane. 36 So, although the different conduct makes comparison between SϩN and PϩN a bit problematic, we believe that our goal to maintain equihypnotic depth was more or less achieved during SϩN, and the increases in rCBF and rCMRO 2 versus sevoflurane alone are essentially valid. It should also be pointed out that sevoflurane concentration was reduced by merely 22%, whereas the rCBF-reducing effect of sevoflurane was entirely abolished. Furthermore, if MAC values are compared, the anesthesia was still deeper during SϩN than during sevoflurane alone.
Irrespective of the depth of anesthesia, the clear reduction in rOEF (vs. awake) during sevoflurane but especially SϩN is important because it suggests that blood flow is no longer tightly regulated by oxygen requirements. On the other hand, regionally, the association between flow and metabolism is not completely abolished because regions of highest rCMRO 2 still had highest the rCBF, and vice versa, during all anesthetic regimens ( fig. 7 ). Especially in a compromised brain, however, a reduced rOEF is most probably an undesir- able phenomenon, irrespective of the actual mechanism. Thus, our findings support the current clinical practice that in such circumstances, volatile anesthetics and N 2 O should be used very cautiously.
Quantitative Effects of Sevoflurane, Propofol, and Adjunct Nitrous Oxide on rCBV
The effects of propofol on rCBV are straightforward. The marked reduction in rCBF was accompanied with a reduction in rCBV, suggesting vasoconstriction to suit the reduced requirements of diminished neuronal activity. This should be a reassuring finding for neuroanesthetists, although our study does not prove that exactly the same occurs in the compromised brain.
Based on previous studies showing that CBV does not reflect CBF 37 or intracranial pressure 38 per se but could correlate inversely with regional cerebral vascular resistance 39 -41 and is globally increased because of N 2 O, 42 halothane, 43 and isoflurane, 38, 43 we hoped that rCBV assessment would help us to estimate the vasodilatory effects of sevoflurane and N 2 O within the cortical tissue. Sevoflurane reduced rCBF by 6 -27% and SϩN maintained it at the awake level, whereas neither regimen affected rCBV. Taking into account the concomitant decrease in blood pressure as shown in figure 8 , rCBV does not seem to reveal the probable vasodilation during SϩN. To examine also, for example, the white matter, we looked for changes in absolute rCBV at voxel-level detail using SPM, showing that SϩN increased blood volume (vs. awake) only in the transverse venous sinus and probably the anterior and medial cerebral arteries ( fig. 6 ) but not within the brain tissue. Thus, our results suggest that rCBV is a fairly insensitive indicator of vasodilation. The most likely reasons for this insensitivity are that even a small change in vascular diameter alters CBF considerably, that the actual resistance vessels represent only a small fraction of the whole blood volume shown by CBV imaging, and/or that anesthesia may cause local changes in capillary hematocrit, 44 which we assumed constant in our measurements.
Results of Voxel-based rCBF and rCMRO 2 Analyses
While quantitative ROI analysis is restricted to anatomic regions manually defined for each brain structure for every individual, SPM explores statistically significant changes for every voxel and enables the localization of the changes according to a common stereotactic atlas. At best, such changes in flow or metabolism may reveal regions with drug-induced changes in neuronal activity. However, in the presence of large global effects, it is important to understand that the effects of the drugs are not restricted to the areas of greatest changes. Furthermore, although regions of least changes can be visualized as well, these findings may not be functionally valid because they seem to contain structures such as white matter with very stable blood flow.
Although rCBF reflects neuronal activity well in normal circumstances and repeated measurements are widely used in neurofunctional studies, interpretation of results becomes difficult when studying drugs that may alter flowactivity coupling. ROI-quantified rCBF and rCMRO 2 provide some assistance because they can be used to verify intact flow-metabolism correlation. If, on the other hand, rOEF is found to be decreased, the reliability of rCBF findings is questionable because a disturbance in flow-activity coupling cannot be excluded. Theoretically, rCMRO 2 could substitute for rCBF in voxel-based analyses during disturbed coupling because it also can be quickly and repeatedly assessed. However, according to the present SPM results with propofol, rCMRO 2 seems to lack the intensity of rCBF changes despite normal rOEF. The reason why rCMRO 2 seems to be a fairly insensitive indicator of regional changes is unclear, but recent evidence suggests that the regional metabolic rate of glucose 45 would actually correlate more directly with neuronal activity than that of oxygen 46 during local activation, whereas flow-CMRO 2 correlation is sustained in the nonactivated regions. 47, 48 This would make regional metabolic rate of glucose more accurate in revealing neuronal activity, but, because certain anesthetics could theoretically alter the glucose-oxygen consumption ratio (see Långsjö et al. 49 in this issue), further studies are needed to establish whether rCMRO 2 or regional metabolic rate of glucose provides a more reliable estimate of neuronal activity. The practical problem in regional metabolic rate of glucose assessments is that using 18 F-fluorodeoxyglucose, a single assessment takes approximately 60 min, and performing repeated assessments in a single session is very difficult (the half-life of 18 F is 110 min). Fig. 8 . Relative changes versus awake in regional cerebral blood flow (rCBF), mean arterial pressure (MAP), and regional cerebral blood volume (rCBV). rCBF and rCBV were calculated as the mean of all regions of interest. P ‫؍‬ propofol; P؉N ‫؍‬ propofol plus nitrous oxide; S ‫؍‬ sevoflurane; S؉N ‫؍‬ sevoflurane plus nitrous oxide. The CBV showed vasoconstriction during propofol and P؉N, matching the concomitant reduction in rCBF. Somewhat surprisingly, rCBV was not increased during S؉N.
Based on the above discussion, the relative rCBF changes by propofol should reflect neuronal activity reasonably well. Because sevoflurane tended to reduce absolute rOEF, neurofunctional deduction should be especially cautious. The relative rCBF effects of sevoflurane and propofol were, however, surprisingly identical in the current study and similar to our own previous study on 1 MAC sevoflurane and 1 EC 50 propofol. 7 The same areas have also shown greatest reductions in voxel-based analysis during 0.7% halothane (with reduced rGMR in the basal forebrain, thalamus, limbic system, cerebellum, and occipital cortex) 50 and 2 g/ml propofol (with reduced rCBF in the frontal and parietal cortex, posterior cingulate, and thalamus) 23 and in ROI-based analysis during sedative concentrations of propofol (with reduction in rCBF in the thalamus, cuneus, precuneus, posterior cingulate, and orbitofrontal and right angular gyri). 24 
Limitations of the Study Design
The nonbalanced design of the current study can be criticized. However, randomization was not considered possible because it would have lengthened the anesthesia considerably if propofol were given before sevoflurane. We also wanted to study the drugs alone and in combination with N 2 O consecutively. The study conditions were rigorously standardized, and we consider significant order effects extremely unlikely, although body temperature was slightly but statistically significantly reduced toward the end of anesthesia. It should also be pointed out that only trace amounts of sevoflurane were detected during the propofol and PϩN periods (table 1), suggesting that the time interval between the PET assessments at different anesthetic regimens was sufficient.
Conclusions
Propofol reduced rCBF and rCMRO 2 comparably at a BIS value of 40. Sevoflurane reduced rCBF less than propofol but rCMRO 2 to an extent similar to propofol. Adjunct N 2 O increased flow and metabolism with both drugs. Sevoflurane, but especially the combination of sevoflurane and N 2 O, decreased rOEF, which may suggest disturbed flow-activity coupling in humans already at a moderate depth of anesthesia.
